Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -1.54 % |
3 Month Return | -2.34 % |
1 Year Return | + 38.65 % |
Market Stats | |
Previous Close | ₹22.96 |
Open | ₹23.50 |
Upper Circuit | - |
Lower Circuit | - |
Insights help you understand the recent movement of the ETF's critical parameters, giving you an overall view of the ETF.
Price Rise
In the last 3 years, Nippon India NIFTY Pharma ETF Growth Plan has moved up by 72.63%
Against Peers
In the last 1 year, Motilal Oswal S&P BSE Healthcare ETF has given 45.09% return, outperforming Nippon India NIFTY Pharma ETF Growth Plan by 6.44%.
Against Peers
In the last 3 year, Aditya Birla Sun Life NIFTY Healthcare ETF has given 73.73% return, outperforming Nippon India NIFTY Pharma ETF Growth Plan by 1.10%.
Market Cap Breakup
Market Cap breakup for Nippon India NIFTY Pharma ETF Growth Plan is 65.17% in LARGE CAP, 25.91% in MID CAP and 8.92% in SMALL CAP with top sector being Pharmaceuticals with 100.00%
Expense Ratio | 0.21% |
Avg. PE ratio | 35.94 |
Avg. PB ratio | 5.52 |
AUM | ₹840.57 Cr. |
Companies | 1D Returns |
Sun Pharmaceuticals Industries Ltd | 0.47 |
Cipla Ltd | 1.39 |
Divis Laboratories Ltd | 0.57 |
Dr Reddys Laboratories Ltd | 1.12 |
Lupin Ltd | 0.4 |
Portfolio Breakup
Sector
Exchange | NSE |
E-voting on shares | Click here to vote |
Nippon India NIFTY Pharma ETF Growth Plan price is ₹22.9 today.
Nippon India NIFTY Pharma ETF Growth Plan | Price |
---|---|
52 Week High | ₹24.53 |
52 Week Low | ₹16.11 |
Nippon India NIFTY Pharma ETF Growth Plan | Returns |
---|---|
1 Day Returns | -0.06% |
1 Month Returns | -1.54% |
3 Month Returns | -2.34% |
1 Year Returns | 38.65% |
Nippon India NIFTY Pharma ETF Growth Plan} price to earning (PE) ratio as on today is 35.94
You can invest via your demat account in the Nippon India NIFTY Pharma ETF Growth Plan. You can invest either through SIP mode or lumpsum mode.
Yes. Nippon India NIFTY Pharma ETF Growth Plan is available for SIP on INDmoney platform for daily, weekly or monthly SIP.
Nippon India NIFTY Pharma ETF Growth Plan's drawbacks are not related to specifically Nippon India NIFTY Pharma ETF Growth Plan. In Indian context, some of the ETFs have a drawbacks of higher tracking, lower trading volumes, etc.
Yes. Nippon India NIFTY Pharma ETF Growth Plan can used as collateral for a loan under Loan Against Securities.